Canary Capital files for Injective staking ETF

Canary Capital files for Injective staking ETF

Canary Capital filed for the first-ever Injective staking ETF in Delaware, as reported on X (formerly Twitter), with the product set to contribute to network security.

Earlier on, 21Shares’ AINJ ETF in Europe had an impact on demand, which suggested the U.S. market could have an even larger one following its size.

The SEC has yet to confirm receipt of the Injective ETF filing. Once acknowledged, it will announce key dates for further updates.

This decision could shape Injective’s long-term trajectory, especially as ETFs become a popular gateway for crypto exposure.

The proposed Canary Staked INJ ETF offers both price exposure and staking rewards, making it a unique tool for investors seeking regulated access to decentralized finance